SPONSORED CONTENT
TIP: Don’t overlook in-house pharmacy capture as a way to maximize your 340B program savings.
Today, fewer than 25% of covered entities are capturing even half of their eligible prescriptions—leaving significant savings and patient impact on the table. With looming changes to the 340B program threatening these critical resources, improving capture has never been more urgent.
Many covered entities are aware of the challenge, yet fewer than 15% have a clear strategy to address it. Patients often don’t understand the benefits of using 340B pharmacies, and providers rarely have the time or tools to educate them during visits.
Our AI-powered analytics and patient engagement tools identify prescription leakage and help you recover it—efficiently and effectively. By guiding patients to your pharmacy, you not only boost adherence and outcomes but also drive sustainable 340B savings.
Reach out to us at hello@compassrx.com to learn more.
Ali Farzad is CEO of CompassRx. He can be reached at ali@compassrx.com
